Natural and Engineered Cytotoxic Ribonucleases: Therapeutic Potential
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 253 (2) , 325-335
- https://doi.org/10.1006/excr.1999.4718
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- Epidermal growth factor receptor-dependent cytotoxicity for human squamous carcinoma cell lines of a conjugate composed of human EGF and RNase 1Life Sciences, 1996
- Role of the N Terminus in RNase A Homologues: Differences in Catalytic Activity, Ribonuclease Inhibitor Interaction and CytotoxicityJournal of Molecular Biology, 1996
- Effects of Protein RNase Inhibitor and Substrate on the Quaternary Structures of Bovine Seminal RNaseBiochemistry, 1996
- Full Antitumor Action of Recombinant Seminal Ribonuclease Depends on the Removal of Its N-Terminal MethionineBiochemical and Biophysical Research Communications, 1995
- The antitumor action of seminal ribonuclease and its quaternary conformationsFEBS Letters, 1995
- Characterization of the Mechanism of Cellular and Cell Free Protein Synthesis Inhibition by an Anti-tumor RibonucleaseBiochemical and Biophysical Research Communications, 1994
- Refined 1·7 Å X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activityJournal of Molecular Biology, 1994
- Immunotoxins: magic bullets or misguided missiles?Trends in Pharmacological Sciences, 1993
- A putative mouse oocyte maturation inhibitory protein from urine of pregnant women: N-terminal sequence homology with human nonsecretory ribonuclease.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- The effect of bovine seminal ribonuclease (AS RNase) on cells of crocker tumour in miceCellular and Molecular Life Sciences, 1973